Navigation Links
Intimate Bridge 2 Conception, Inc. Receives $4.3M
Date:12/22/2011

n the privacy of the home. The Stork™ is a simple, private, non-pharmaceutical and economical method to help expedite and overcome many of the infertility issues of today's patient population.

Steve Bollinger brings a diverse background with respect to the medical device and biologic market place. He has held multiple leadership positions from a Founder, President and Chief Operations Officer, of early stage companies, to a broad spectrum of roles not limited to, global operations, marketing, product management and sales. He is currently an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse.

Mr. Bollinger currently holds seven medical patents, with multiple pending. He is a graduate of the United States Military Academy West Point with a BS in mechanical engineering. He has raised over $50 million over the last 10 plus years while delivering strong returns to his investors.

About the PLSG Accelerator Fund, LLC

The PLSG Accelerator Fund, LLC venture fund is a $10 million for-profit venture fund with an investment period of up to five years. The PLSG Accelerator Fund, LLC is designed to make early stage investments in life sciences companies located in western Pennsylvania.  The Accelerator Fund is managed by professionals on the Pittsburgh Life Sciences Greenhouse (PLSG) staff and will use the PLSG's deep knowledge of global industry trends, access to industry contacts nationwide and experience in corporate collaborations to identify worthy investment opportunities within western Pennsylvania from the portfolio of PLSG companies. The Accelerator Fund also makes co-investment in portfolio companies with other venture capital funds.


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
2. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
3. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
4. Narrowest bridges of gold are also the strongest, study finds
5. Core Informatics Announces Second Office Location in Cambridge Massachusetts
6. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
7. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
8. The iBridge Network Adds Torontos University Health Network as First Canadian Partner
9. Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
10. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
11. Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... Worms, Germany (PRWEB) May 21, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACTâ„¢, an independent subsidiary of the International Pharmaceutical ... three Grace facilities that produce its SYLOID® FP ... now received GMP certification, following the Curtis Bay, ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... ISOT ) ("IsoTis"), an orthobiologics company, today announced that,it ... US Food and Drug,Administration ("FDA"), clearing the Accell Family ... medical devices. The Accell Family of Products includes ... well as a new Accell product that is not,currently ...
... CEL-SCI Corporation,(Amex: CVM ), will present ... South Carolina. On August 20, 2007 at ... give a 25-minute presentation regarding CEL-SCI,s late stage,cancer ... a question,and answer session following the presentation and ...
... and Increased Space, Poised for Market Launch, KIRKLAND, ... developing innovative devices for the treatment of arterial,disease, today ... Joseph W.,Rafferty, and has started building its sales team ... PV(TM) Atherectomy System. Recently Pathway moved from its ...
Cached Biology Technology:IsoTis Receives FDA Clearance for Accell Family of Products 2IsoTis Receives FDA Clearance for Accell Family of Products 3IsoTis Receives FDA Clearance for Accell Family of Products 4CEL-SCI to Present at the Noble Financial Conference 2Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
(Date:4/13/2015)... According to a recently ... & Opportunities, 2020", the global biometrics market is ... till 2020. The biometrics market is garnering attention ... review of biometric management systems. The constant development ... greater efficiency, are resulting in increasing installation of ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... orchestrated by a spectrum of signals from hormones within ... cytokinins originate in the roots of plants, and their ... leaves stimulates plant development. Though these phytohormones have been ... their transportation within plants was previously poorly understood. ...
... PA, February 20, 2014 Schizophrenia has long been known ... of the population. Researchers have been following two paths in ... they studied common gene variants that, individually, only increase the ... likelihood of developing schizophrenia from a 10 out of a ...
... fruits and vegetables are associated with higher Body Mass ... households, according to American University researchers in the journal ... significant, association between the prices of fruit and vegetables ... lead author and assistant professor of public administration and ...
Cached Biology News:Roots to shoots: Hormone transport in plants deciphered 2Gathering the clues to rare gene variants contributing to schizophrenia 2High cost of fruits, vegetables linked to higher body fat in young children 2
Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...
The Protein Kinase Factsbooks (2 Volume Set)...
... Edited by John M. Walker (1996) ... successful analytical techniques for studying proteins ... protocol contains detailed, step-by-step instruction, timesaving ... and comprehensive lists of reagents and ...
All serum is collected from U.S.D.A. fryers and broilers. Pricing: $15/unit for 1 - 10 units; $12/unit for 11 - 50 units...
Biology Products: